Prescription drug · ANDA
Amlodipine besylate and Atorvastatin calcium NDC 43598-313
Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 80 mg/1 · Tablet, Film coated · Oral · Dr. Reddy's Laboratories Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43598-313-05 | 43598031305 | 500 TABLET, FILM COATED in 1 BOTTLE (43598-313-05)Marketed from Mar 17, 2014 | |
| 43598-313-30 | 43598031330 | 30 TABLET, FILM COATED in 1 BOTTLE (43598-313-30)Marketed from Mar 17, 2014 | |
| 43598-313-60 | 43598031360 | 60 TABLET, FILM COATED in 1 BOTTLE (43598-313-60)Marketed from Mar 17, 2014 | |
| 43598-313-90 | 43598031390 | 90 TABLET, FILM COATED in 1 BOTTLE (43598-313-90)Marketed from Mar 17, 2014 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Amlodipine besylate and Atorvastatin calcium
- Generic name (nonproprietary)
- amlodipine besylate and atorvastatin calcium
- Active ingredients
- Amlodipine besylate — 10 mg/1Atorvastatin calcium trihydrate — 80 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Dr. Reddy's Laboratories Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203874
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Dihydropyridines (Chemical structure)Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
- Identifiers
- Product ID 43598-313_54058ac6-94e2-d2d3-5c46-886b3478fc76SPL ID 54058ac6-94e2-d2d3-5c46-886b3478fc76SPL set ID abee4a34-89cc-d886-192c-32582ab8f024RxCUI 404011, 404013, 597967, 597971, 597974, 597977, 597980, 597984, 597987, 597990, 597993UNII 864V2Q084H, 48A5M73Z4QUPC 0343598323305, 0343598315300, 0343598320304, 0343598317304, 0343598313306, 0343598322308, 0343598319308, 0343598316307, 0343598314303
- Pharmacologic class
- Dihydropyridine Calcium Channel Blocker; HMG-CoA Reductase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N443598031305followed by a unit qualifier and the quantityPackage 43598-0313-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Amlodipine besylate and atorvastatin calcium tablets are indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. Amlodipine Amlodipine besylate and atorvastatin calcium tablets are a combination of amlodipine besylate, a calcium channel blocker, and atorvastatin calcium, a HMG CoA-reductase inhibitor, indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. Amlodipine is indicated for the treatment of hypertension, to lower blood pressure (1.1). Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Amlodipine is indicated for the treatment…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203874
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-319 |
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 2.5 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-320 |
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-321 |
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-322 |
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 2.5 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-323 |
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-314 |
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-318 |
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-315 |
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-316 |
| Amlodipine besylate and Atorvastatin calcium | Amlodipine besylate 2.5 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Inc | 43598-317 |
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.